Cancer In The Canine-References

wnwbanner.jpg (27305 bytes)

Pamela A. Davol, 76 Mildred Avenue, Swansea, MA 02777-1620.
pdavol@labbies.com

Cancer In The Canine

References:

Part 1, Part 2, and Part 3.

In Cancer: Principles and Practice of Oncology, 5th edition, V.T. DeVita, Jr., S. Hellman, S.A. Rosenberg (eds.) Lippincott-Raven Publishers, Philadelphia, 1997:

Perkins, A.S. and Stern, D.F. Molecular Biology of Cancer: Oncogenes, pp 79-101.
LeBeau, M.M. Molecular Biology of Cancer: Cytogenetics, pp 103-119.
Kastan, M.B. Molecular Biology of Cancer: The Cell Cycle, pp 121-133.
Fidler, I.J. Molecular Biology of Cancer: Invasion and Metastasis, pp 135-151.
Poeschla, E.M. and Wong-Staal, F. RNA Viruses, pp 153-166.
Howley, P.M., Ganem, D., and Kieff, E. DNA Viruses, pp 168-183.
Yuspa, S.H. and Shields, P.G. Etiology of Cancer: Chemical Factors, pp 185-201.
Hall, E.J. Etiology of Cancer: Physical Factors, pp 203-217.
Henderson, B.E., Bernstein, and Ross, R. Etiology of Cancer: Hormonal Factors, pp 219-229.
Bale, A.E. and Li, F.P. Principles of Cancer Management: Cancer Genetics, pp285-293.

In Cancer Medicine, 4th Edition, Holland, J.F. et al. (eds.), Williams and Wilkins, Baltimore, 1997:

Bast, R.C., Jr., Mills, G.B., Gibson, S., and Boyer, C.M. Tumor Immunology, pp 207-242.
Folkman, J. Angiogenesis. pp

In Kirk's Current Veterinary Therapy XII, Bonagura, J.D. (ed.), W.B. Saunders Co., Philadelphia, 1995:

Vail, D.M. Treatment and Prognosis of Canine Malignant Lymphoma, pp 494-498.
Hammer, A.S. and Couto, C.G. Nonsurgical Management of Soft Tissue Sarcomas, pp 502-506.
Straw, R.C. and Winthrow, S.J. Treatment of Canine Osteosarcoma, pp 506-511.
Madewell, B.R. Treatment of Skin Cancer, pp 511-518.
Rutteman, G.R. Mammary Tumors in the Dog, pp 518-523.
Fox, L.E. The Paraneoplastic Disorders, pp 530-542.
Birchard SJ. Definitive Surgical Treatment for Cancer. pp. 462-467.
Gorman NT. Tumor Immunolgy and Tumor Immunotherapy. pp. 488-494.
Theon AP. Indications and Applications of Radiation Therapy. pp. 467-474.

In Kirk's Current Veterinary Therapy XIII, Bonagura, J.D. (ed.), W.B. Saunders Co., Philadelphia, 1999:

DewHirst MW. Hyperthermia. pp.486-493.

Elmslie RE, Dow SW. Gene Therapy for Cancer. pp.493-498.

Frimberger AE. Anticancer Drugs: New Drugs or Applications for Veterinary Medicine. pp.474-478.

Kitchell BE, Dhaliwal RS. CVT Update: Anticancer Drugs and Protocols Using Traditional Drugs. pp.465-473.

Mauldin GE. Nutritional Support of the Cancer Patient. pp.458-462.

McEntee MC. Radiation Therapy: Systems of Application and Eligible Patients. pp. 482-485.

Ma, Y. et al. Clustering of activating mutations in cKIT's juxtamembrane coding region in canine mast cell neoplasms. J. Invest. Dermatol., 112:165-70, 1999.

London, C.A. et al. Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit. Exp. Hematol., 27:689-97, 1999.

Rungsipipat, A. et al. Amplification of the c-yes oncogene in canine mammary tumors. J. Vet. Med. Sci., 61:185-9, 1999.

Kaneene, JB and Miller, R. Re-analysis of 2,4-D use and the occurrence of malignant lymphoma. Vet. Hum. Toxicol., 41:164-70, 1999.

Veldhoen, N. et al. Mutations of the p53 gene in canine lymphoma and evidence for germ line p53 mutations in the dog. Oncogene, 16:249-55, 1998.

Kiupel, M. et al. Prognostic factors for treated canine malignant lymphoma. Vet Pathol., 36:292-300, 1999.

Hahn, K.A. et al. Detection and clinical significance of plasma glutathione-s-transferases in dogs with lymphoma. In Vivo, 13:173-5, 1999.

Kiupel, M. et al. The prognostic significance of AgNOR counts and PCNA-positive cell counts in canine malignant lymphoma. J. Comp. Pathol., 119:407-18, 1998.

Bukowski, J.A. et al. Environmental causes for sinonasal cancers in pet dogs, and their usefulness as sentinels of indoor cancer risk. J. Toxicol. Environ. Health, 54:579-91, 1998.

Suzich, J.A. et al. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. USA, 92:11553-7, 1995.

Coomber, B.L. et al. Blood vessel density in canine osteosarcoma. Can. J. Vet. Res., 62:199-204, 1998.

Marcellin-Little, D.J. et al. Osteosarcoma at the site of bone infarction associated with total hip arthroplasty in a dog. Vet. Surg., 28:54-60, 1999.

Ru, G. et al. Host related risk factors for canine osteosarcoma. Vet. J., 156:31-9, 1998.

Johnson, A.S. et al. Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog. Carcinogenesis, 19:213-7, 1998.

Davol PA, Frackelton AR Jr, Calabresi P. Growth-factor toxin chimeras and their applications. In: Growth Factors and Receptors: A Practical Approach. McKay IA, Brown KD (eds), Oxford University Press, Oxford, 1998. pp.199-225.

Back To Cancer In The Canine--Table of Contents
Back To Main Menu